Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Overview

This article presents a mediator release assay using a rat basophilic leukemia cell line to simulate degranulation in type 1 allergic reactions. The method is robust, reproducible, and highly sensitive, allowing for the analysis of allergens with minimal sample amounts.

Key Study Components

Area of Science

• Allergy research
• Immunology
• Cell biology

Background

• The assay mimics degranulation of basophils induced by IgE cross-linking.
• It is used to diagnose allergies and analyze reactivity to allergens.
• The method can assess cross-reactivity and monitor allergen immunotherapy treatment efficacy.
• It allows for the use of small amounts of allergens, including complex extracts.

Purpose of Study

• To develop a sensitive assay for studying allergic reactions.
• To evaluate the reactivity of patient IgE to various allergens.
• To assess the hypoallergenic nature of allergen variants.

Methods Used

• Harvesting and preparing rat basophilic leukemia cells.
• Incubating cells with human sera to sensitize them.
• Performing a beta-hexosaminidase activity assay to measure degranulation.
• Analyzing cross-reactivity and allergen potency using linear regression.

Main Results

• Four out of five sera from birch pollen allergy patients responded to Bet v 1.
• Cross-reactivity was observed with homologous allergens.
• Mutant variants of allergens showed reduced allergenic potential.
• The assay demonstrated a bell-shaped curve indicating monovalent occupation of IgE.

Conclusions

• The mediator release assay is a valuable tool for allergy research.
• It can effectively evaluate allergen reactivity and cross-reactivity.
• Mutant allergens may serve as candidates for immunotherapy.

Frequently Asked Questions